Venus Remedies Limited (NSE:VENUSREM)
India · Delayed Price · Currency is INR 896.60
+35.55 (4.13%)
Apr 2, 2026, 3:29 PM IST
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 12 billion as of April 2, 2026. Its market cap has increased by 207.28% in one year.
Market Cap
12.00B
Enterprise Value
9.78B
Revenue
7.03B
Ranking
n/a
PE Ratio
15.72
Stock Price
896.60
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 12.00B, an increase of 4,839.83%. That is a compound annual growth rate of 19.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 12.00B | 17.00% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 40.26B |
| RPG Life Sciences | 31.77B |
| Orchid Pharma | 26.57B |
| Solara Active Pharma Sciences | 22.93B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |
| Beta Drugs | 14.00B |
| Jagsonpal Pharmaceuticals | 12.47B |